Superpower is a technology company.
Superpower has raised $34.0M across 2 funding rounds.
Superpower has raised $34.0M in total across 2 funding rounds.
Superpower has raised $34.0M in total across 2 funding rounds.
Superpower's investors include Acrew Capital, Adverb Ventures, AirAngels, AngelCube, ATX Venture Partners, Bain Capital Ventures, Canaan Partners, CP Ventures, Craft Ventures, Curie.Bio, Curious Capital, FJ Labs.
Superpower is a Los Angeles-based health tech startup founded in 2023 that operates a digital clinic offering comprehensive biomarker testing and personalized health optimization services.[3][5] It serves individuals focused on preventive health and longevity, solving the problem of fragmented health data and reactive care by providing an all-in-one platform with over 100 biomarkers tested via partnerships like Quest Labs, biological age reports, personalized action plans, unlimited concierge support, and access to a clinic marketplace.[3][5] The company has raised $34M in Series A funding, signaling strong growth momentum in the personal health sector, with backing from investors like Forerunner Ventures, Susa Ventures, and Day One Ventures.[3]
Superpower positions itself as a "health super-app" bridging wellness and healthcare, making advanced diagnostics accessible at a fraction of concierge clinic costs (e.g., via annual memberships eligible for HSA/FSA), emphasizing early detection, prevention, and lifetime health tracking.[3][5]
Superpower was founded in 2023 in Los Angeles, California, by a team including co-founder Max Marchione, an Australian entrepreneur, amid a push to disrupt traditional healthcare models.[3] The idea emerged from recognizing gaps in preventive health: combining diagnostics, data tracking, and actionable insights into one platform to empower users with "clarity and confidence" in their health journey, contrasting reactive insurance-based care.[3][5] Early traction came swiftly with a $34M Series A round shortly after launch, led by Forerunner Ventures and including high-profile investors like Winklevoss Capital and Steve Aoki, validating its focus on biomarker-driven longevity.[3] Pivotal moments include partnerships with Quest Labs for core testing and top clinicians like Harvard MD Dr. Anant Vinjamoori as Chief Longevity Officer, accelerating development of its membership model.[5]
Superpower rides the explosive longevity and preventive health trend, fueled by rising demand for personalized medicine amid aging populations and post-pandemic health awareness.[3][5] Timing is ideal: biomarker tech and AI-driven insights are maturing, with market forces like expanding at-home testing (e.g., Quest partnerships) and investor appetite for health tech (evident in its quick $34M raise) working in its favor.[3] It influences the ecosystem by democratizing elite care—once limited to high-net-worth individuals—pushing incumbents toward prevention and fostering a data-centric model that could integrate with wearables, telehealth, and insurers for broader adoption.[5]
Superpower is poised to scale as the "world's first health super-app," expanding testing capabilities, geographic reach beyond current US states, and marketplace offerings while leveraging its clinician network for Rx integrations.[3][5] Trends like AI biomarker analysis, multimodal data (e.g., wearables + labs), and regulatory shifts toward prevention will shape its path, potentially evolving it into a full-stack longevity platform challenging Big Pharma's reactive paradigms. With $34M fuel and a prevention-first hook, Superpower could redefine personal health intelligence for millions, turning data into decades of vitality.[3][5]
Superpower has raised $34.0M across 2 funding rounds. Most recently, it raised $30.0M Series A in April 2025.